143 related articles for article (PubMed ID: 31892858)
1. Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK-Mfn2 signaling pathway.
Song J; Zhao W; Lu C; Shao X
Cancer Cell Int; 2019; 19():359. PubMed ID: 31892858
[TBL] [Abstract][Full Text] [Related]
2. LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway.
Song J; Zhao W; Lu C; Shao X
Cancer Cell Int; 2019; 19():60. PubMed ID: 30923462
[TBL] [Abstract][Full Text] [Related]
3. Retraction: Mfn2 overexpression attenuates Cardio-Cerebrovascular Ischemia-Reperfusion injury through mitochondrial fusion and activation of the AMPK/Sirt3 signaling.
Frontiers Editorial Office
Front Cell Dev Biol; 2022; 10():1006496. PubMed ID: 35990613
[TBL] [Abstract][Full Text] [Related]
4. Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway.
Ding X; Sun W; Chen J
Cancer Cell Int; 2019; 19():358. PubMed ID: 31892857
[TBL] [Abstract][Full Text] [Related]
5. LATS2 promotes cardiomyocyte H9C2 cells apoptosis via the Prx3-Mfn2-mitophagy pathways.
Tian Y; Lv W; Lu C; Zhao X; Zhang C; Song H
J Recept Signal Transduct Res; 2019; 39(5-6):470-478. PubMed ID: 31829064
[No Abstract] [Full Text] [Related]
6. Retraction Note: Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines.
Wang Y; Chen X; Sun Q; Zang W; Li M; Dong Z; Zhao G
Cancer Cell Int; 2019; 19():88. PubMed ID: 30996688
[TBL] [Abstract][Full Text] [Related]
7. PTEN inhibition attenuates endothelial cell apoptosis in coronary heart disease via modulating the AMPK-CREB-Mfn2-mitophagy signaling pathway.
Li P; Wang J; Zhao X; Ru J; Tian T; An Y; Tang L; Bai Y
J Cell Physiol; 2020 May; 235(5):4878-4889. PubMed ID: 31654396
[TBL] [Abstract][Full Text] [Related]
8. Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways.
Wan J; Cui J; Wang L; Wu K; Hong X; Zou Y; Zhao S; Ke H
Cancer Cell Int; 2019; 19():286. PubMed ID: 31736657
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ERβ Participates in the Progression of Liver Cancer via Inhibiting the Notch Signaling Pathway [Retraction].
Onco Targets Ther; 2020; 13():6849. PubMed ID: 32764973
[TBL] [Abstract][Full Text] [Related]
10. Retraction Note to: Mutation pattern is an influential factor on functional mutation rates in cancer.
Du C; Wu X; Li J
Cancer Cell Int; 2017; 17():67. PubMed ID: 28690427
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effect of LATS2 on liver cancer death: Role of DRP1-mediated mitochondrial division and the Wnt/β-catenin pathway.
Zhang L; Li S; Wang R; Chen C; Ma W; Cai H
Biomed Pharmacother; 2019 Jun; 114():108825. PubMed ID: 30981110
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.
Asian Pac J Cancer Prev; 2017 Nov; 18(10):2895-2895. PubMed ID: 29171745
[TBL] [Abstract][Full Text] [Related]
13. Retraction Note: Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans.
Liu G; Wu Q; Liu G; Song X; Zhang J
Cancer Cell Int; 2016; 16():40. PubMed ID: 27252596
[TBL] [Abstract][Full Text] [Related]
14. Retraction Note to: Correlations between chromobox homolog 8 and key factors of epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhu X; Luo W; Bei C; Kong J; Zhang S; Fu Y; Li D; Tan S
Cancer Cell Int; 2020; 20():486. PubMed ID: 33041667
[TBL] [Abstract][Full Text] [Related]
15. Retraction Note: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
Mirghasemi A; Taheriazam A; Karbasy SH; Torkaman A; Shakeri M; Yahaghi E; Mokarizadeh A
Cancer Cell Int; 2016; 16():84. PubMed ID: 27822140
[TBL] [Abstract][Full Text] [Related]
16. Retraction Note: Long noncoding RNA ANRIL is activated by hypoxia-inducible factor-1α and promotes osteosarcoma cell invasion and suppresses cell apoptosis upon hypoxia.
Wei X; Wang C; Ma C; Sun W; Li H; Cai Z
Cancer Cell Int; 2017; 17():60. PubMed ID: 28588425
[TBL] [Abstract][Full Text] [Related]
17. Retraction: Overexpression of SERCA2a alleviates cardiac microvascular ischemic injury by suppressing Mfn2-mediated ER/mitochondrial calcium tethering.
Frontiers Editorial Office
Front Cell Dev Biol; 2022; 10():1006540. PubMed ID: 35990600
[TBL] [Abstract][Full Text] [Related]
18. LATS2 promotes apoptosis in non-small cell lung cancer A549 cells via triggering Mff-dependent mitochondrial fission and activating the JNK signaling pathway.
Xie Y; Lv Y; Zhang Y; Liang Z; Han L; Xie Y
Biomed Pharmacother; 2019 Jan; 109():679-689. PubMed ID: 30551520
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Mst1 Reduces Gastric Cancer Cell Viability by Repressing the AMPK-Sirt3 Pathway and Activating Mitochondrial Fission [Retraction].
Onco Targets Ther; 2024; 17():281-282. PubMed ID: 38586816
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of macrophage stimulating 1 enhances the anti-tumor effects of IL-24 in esophageal cancer via inhibiting ERK-Mfn2 signaling-dependent mitophagy.
Zhang J; Sun L; Li W; Wang Y; Li X; Liu Y
Biomed Pharmacother; 2019 Jun; 114():108844. PubMed ID: 30981108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
